QCM
AKCA

Quantinno Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Quantinno Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26,770
Closed -$758K – 546
2019
Q1 		$758K Buy
+26,770
New +$780K 0.49% 31

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Quantinno Capital Management's AKCA Position: Q2 2019 in Review

Quantinno Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q2 2019, closing a stake of 26,770 shares — an estimated $758K sold.

Quantinno Capital Management first reported a position in AKCA in Q1 2019 and held it in 1 quarter. The position peaked at $758K in Q1 2019. 68 funds tracked by Wall St. Rank hold AKCA as of Q2 2019.

  • Quantinno Capital Management reported no remaining Akcea Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • Quantinno Capital Management sold 26,770 Akcea Therapeutics Inc shares in Q2 2019, an estimated $758K.
  • Quantinno Capital Management first reported a position in Akcea Therapeutics Inc in Q1 2019 and held it in 1 quarter.
  • Quantinno Capital Management's Akcea Therapeutics Inc position peaked at $758K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2019.

Based on Quantinno Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.